Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US9345771 | BENUVIA | Oral cannabinoid formulations |
Aug, 2028
(5 years from now) | |
US8222292 | BENUVIA | Liquid cannabinoid formulations |
Aug, 2028
(5 years from now) | |
US10265293 | BENUVIA | Oral cannabinoid formulations |
Aug, 2028
(5 years from now) | |
US11253472 | BENUVIA | Oral cannabinoid formulations |
Aug, 2028
(5 years from now) |
Drugs and Companies using DRONABINOL ingredient
Market Authorisation Date: 23 March, 2017
Treatment: NA
Dosage: SOLUTION;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic